To learn more about our clinical studies of investigational gene therapies in transfusion-dependent β-thalassemia, severe sickle cell disease, cerebral adrenoleukodystrophy, and relapsed/refractory multiple myeloma, visit our clinical trials page.
This site implements cookies to improve your experience: Find out more.
You are now leaving www.bluebirdbio.com. Links to sites outside of this website are provided as a resource
to the viewer. bluebird bio accepts no responsibility for the content of linked sites.